GIBH-130
A novel inhibitor of neuroinflammation, suppresses the proinflammatory cytokine production in LPS-stimulated N9 microglial cells (IC50=3.4 nM) ; modulates the release of detrimental proinflammatory cytokines; exhibits in vivo efficacy of cognitive impairment in both β amyloid-induced and APP/PS1 double transgenic Alzheimer's murine models.Alzheimer's Disease Phase 1 Clinical.
Product Specifications
CAS Number
1252608-59-5
Product Name Alternative
GIBH 130 | GIBH130
Purity
>98% (HPLC)
Solubility
< 1 mg/ml refers to the product slightly soluble or insoluble
Smiles
O=C (C1=NN=C (C2=CC=CC=C2) C=C1C) N3CCN (C4=NC=CC=N4) CC3
Molecular Formula
C20H20N6O
Molecular Weight
360.421
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(4-methyl-6-phenylpyridazin-3-yl) (4- (pyrimidin-2-yl) piperazin-1-yl) methanone
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL306709V 500 µL Each
ANKHD1 Human shRNA Lentiviral Particle (Locus ID 54882)
Sign In for Pricing
View Details 
38232151 3x 1.0 µg DNA
PWWP2B CRISPR All-in-one AAV vector set (with saCas9)(Human)
Sign In for Pricing
View Details